Telo Genomics Patents Liquid Biopsy Myeloma MRD

Company Telo Genomics Corp. (TSXV: TELO; OTCQB: TDSGF) Event Type U.S. provisional patent application filing — intellectual property expansion Modality Liquid biopsy minimal residual disease (MRD) diagnostics — 3D telomere quantitative analysis with AI-based genetic instability recognition Platform TeloView biomarker algorithm Indication Multiple Myeloma —…